首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1236106

全球毛细胞白血病市场：规模、研究和预测，按治疗（化疗、靶向治疗）、区域分析，2022-2029 年

Global Hairy Cell Leukemia Market Size study & Forecast, by Therapy (Chemotherapy and Targeted Therapy) and Regional Analysis, 2022-2029

出版日期: 2023年02月27日 | 出版商:

Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

简介目录图表

毛细胞白血病是一种骨髓产生过多淋巴细胞的癌症。

它是血液和骨髓的恶性肿瘤。它保持稳定多年并引起感染。由于预测期内白血病患病率上升和诊断率提高等因素，毛细胞白血病市场正在扩大。

根据美国癌症协会 2022 年的数据，到 2022 年将诊断出约 60,650 例新的白血病（所有类型）病例，其中约有 20,160 例新的慢性淋巴细胞白血病 (CLL) 病例。根据同一份文件，CLL 还占新诊断白血病的大约四分之一。此外，根据 2021 年 NORD 的数据，大约有 6,000 人患有毛细胞白血病，美国每年诊断出 600-800 例新病例。另一方面，市场参与者对癌症治疗进展的支出增加以及研发活动的增加正在为市场创造有利可图的机会。然而，缺乏意识和有限的医疗服务阻碍了整个 2022-2029 年预测期内的市场增长。

全球毛细胞白血病市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于老年人口不断增长和慢性淋巴细胞白血病患病率上升，北美在收入方面占据了市场主导地位。另一方面，由于研发费用增加和药品成本增加等因素，预计北美在预测期内将以最高复合年增长率增长。

近期市场趋势

2022 年 8 月，阿斯利康的 Calquence 片剂上市，用于治疗慢性淋巴细胞白血病 (CLL)、小淋巴细胞白血病 (SLL) 和先前治疗过的复发或难治性套细胞淋巴瘤 (MCL)，并获得 FDA 批准。
2022 年 5 月，吉森大学开展了一项 2/3 期临床试验，评估毛细胞白血病患者皮下注射克拉屈滨一个週期的疗效和副作用。

全球毛细胞白血病市场报告范围

历史数据：2019-2020-2021
估算基准年：2021 年
预测期：2022-2029
报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
定制范围：免费报告定制（最多 8 个工作小时）。按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

市场概况
2019-2029 年各细分市场的全球市场估计和预测
- 2019-2029 年按地区划分的软细胞白血病市场
- 2019-2029 年按治疗分类的软细胞白血病市场
主要趋势
调查方法
调查先决条件

第 2 章全球毛细胞白血病市场定义和范围

调查目的
市场定义和范围
- 调查范围
- 工业发展
本次调查涵盖的年份
货币兑换率

第 3 章毛细胞白血病的全球市场动态

毛细胞白血病市场影响分析 (2019-2029)
- 市场驱动力
  - 白血病患病率上升
  - 不断增长的诊断率
- 市场挑战
  - 缺乏认识且医疗服务有限
- 市场机会
  - 增加用于推进癌症治疗的支出
  - 激活市场参与者的研发活动

第 4 章全球毛细胞白血病市场行业分析

波特 5 力模型
- 供应商的议价能力
- 买家的议价能力
- 新进入者的威胁
- 替代品的威胁
- 竞争公司之间的敌对关係
波特 5 力模型的未来方法 (2019-2029)
害虫分析
- 政治
- 经济的
- 社交
- 技术
最佳投资机会
关键成功策略
业内人士的前景
分析师的建议和结论

第 5 章风险评估 COVID-19 影响

评估 COVID-19 对行业的总体影响
COVID-19 之前和 COVID-19 之后的市场情景

第 6 章。全球毛细胞白血病市场：按治疗分类

市场概况
全球毛细胞白血病市场：按疗法、按性能 - 潜力分析
2019-2029 年全球毛细胞白血病市场按治疗方法估算和预测
毛细胞白血病市场细分分析
- 化疗
- 靶向治疗

第 7 章。全球毛细胞白血病市场：区域分析

细胞白血病市场，按地区划分的市场概况
北美
- 美国
  - 按疗法估算和预测，2019-2029 年
- 加拿大
欧洲毛细胞白血病市场概况
- 英国
- 德国
- 法国
- 西班牙
- 意大利
- 其他欧洲
亚太地区毛细胞白血病市场概况
- 中国
- 印度
- 日本
- 澳大利亚
- 韩国
- 其他亚太地区
拉丁美洲毛细胞白血病市场概况
- 巴西
- 墨西哥
- 其他拉丁美洲地区
世界其他地区

第 8 章衝突信息

顶级市场策略
公司简介
- 安进公司
  - 关键信息
  - 概览
  - 财务（仅当数据可用时）
  - 产品概述
  - 近期趋势
- AstraZeneca PLC
- Gilead Sciences
- F. Hoffmann-La Roche Ltd
- Astellas Pharma
- Johnson & Johnson
- Merck KGaA
- Biogenomics Limited
- AbbVie Inc.
- Pfizer Inc.

第九章研究过程

研究过程
- 数据挖掘
- 分析
- 市场评估
- 验证
- 出版
调查的特点
调查先决条件

简介目录图表

The global Hairy Cell Leukemia Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Hairy Cell Leukemia is a type of cancer in which the bone marrow produces an excessive number of lymphocytes. It is a blood and bone marrow malignancy. It remains stable for years and creates infections. The Hairy Cell Leukemia market is expanding because of factors such as the rising prevalence of leukemia and growing diagnosis rate in the forecast period.

According to the American Cancer Society's 2022 data, nearly 60,650 new cases of leukemia (all types) are expected to be diagnosed in 2022, with chronic lymphocytic leukemia (CLL) accounting for approximately 20,160 new cases. Furthermore, according to the same source, CLL accounts for roughly one-quarter of newly diagnosed cases of leukemia. Furthermore, according to NORD data for 2021, approximately 6,000 people are affected by hairy cell leukemia, with 600-800 new cases diagnosed in the United States each year. Whereas rising spending towards the advancement of cancer treatment and growing R&D activities by market players create lucrative opportunities for the market. However, a lack of awareness and limited health services hamper the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Hairy Cell Leukemia Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing geriatric population, and growing prevalence of chronic lymphocytic leukemia. Whereas North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing demand spending on research and development and growing pharmaceutical spendings.

Major market players included in this report are:

Amgen Inc.
AstraZeneca PLC
Gilead Sciences
F. Hoffmann-La Roche Ltd
Astellas Pharma
Johnson & Johnson
Merck KGaA
Biogenomics Limited
AbbVie Inc.
Pfizer Inc.

Recent Developments in the Market:

In August 2022, AstraZeneca's Calquence tablet was approved by the FDA for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL), and previously treated relapsed or refractory mantle cell lymphoma (MCL).
In May 2022, The University of Giessen conducted a Phase II/III clinical study to evaluate the efficacy and side effects of one cycle of subcutaneous cladribine treatment in patients with hairy cell leukemia.

Global Hairy Cell Leukemia Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Therapy, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

Chemotherapy
Targeted Therapy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Hairy Cell Leukemia Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Hairy Cell Leukemia Market, by Therapy, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Hairy Cell Leukemia Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Hairy Cell Leukemia Market Dynamics

3.1. Hairy Cell Leukemia Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising prevalence of leukemia
  - 3.1.1.2. Growing diagnosis rate
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of awareness and limited health services
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising spending towards advancement of cancer treatment
  - 3.1.3.2. Growing R&D activities by market players

Chapter 4. Global Hairy Cell Leukemia Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Hairy Cell Leukemia Market, by Therapy

6.1. Market Snapshot
6.2. Global Hairy Cell Leukemia Market by Therapy, Performance - Potential Analysis
6.3. Global Hairy Cell Leukemia Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
6.4. Hairy Cell Leukemia Market, Sub-Segment Analysis
- 6.4.1. Chemotherapy
- 6.4.2. Targeted Therapy

Chapter 7. Global Hairy Cell Leukemia Market, Regional Analysis

7.1. Hairy Cell Leukemia Market, Regional Market Snapshot
7.2. North America Hairy Cell Leukemia Market
- 7.2.1. U.S. Hairy Cell Leukemia Market
  - 7.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Hairy Cell Leukemia Market
7.3. Europe Hairy Cell Leukemia Market Snapshot
- 7.3.1. U.K. Hairy Cell Leukemia Market
- 7.3.2. Germany Hairy Cell Leukemia Market
- 7.3.3. France Hairy Cell Leukemia Market
- 7.3.4. Spain Hairy Cell Leukemia Market
- 7.3.5. Italy Hairy Cell Leukemia Market
- 7.3.6. Rest of Europe Hairy Cell Leukemia Market
7.4. Asia-Pacific Hairy Cell Leukemia Market Snapshot
- 7.4.1. China Hairy Cell Leukemia Market
- 7.4.2. India Hairy Cell Leukemia Market
- 7.4.3. Japan Hairy Cell Leukemia Market
- 7.4.4. Australia Hairy Cell Leukemia Market
- 7.4.5. South Korea Hairy Cell Leukemia Market
- 7.4.6. Rest of Asia Pacific Hairy Cell Leukemia Market
7.5. Latin America Hairy Cell Leukemia Market Snapshot
- 7.5.1. Brazil Hairy Cell Leukemia Market
- 7.5.2. Mexico Hairy Cell Leukemia Market
- 7.5.3. Rest of Latin America Hairy Cell Leukemia Market
7.6. Rest of The World Hairy Cell Leukemia Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Company Profiles
- 8.2.1. Amgen Inc.
  - 8.2.1.1. Key Information
  - 8.2.1.2. Overview
  - 8.2.1.3. Financial (Subject to Data Availability)
  - 8.2.1.4. Product Summary
  - 8.2.1.5. Recent Developments
- 8.2.2. AstraZeneca PLC
- 8.2.3. Gilead Sciences
- 8.2.4. F. Hoffmann-La Roche Ltd
- 8.2.5. Astellas Pharma
- 8.2.6. Johnson & Johnson
- 8.2.7. Merck KGaA
- 8.2.8. Biogenomics Limited
- 8.2.9. AbbVie Inc.
- 8.2.10. Pfizer Inc.

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

简介目录图表

LIST OF TABLES

TABLE 1. Global Hairy Cell Leukemia Market, report scope
TABLE 2. Global Hairy Cell Leukemia Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Hairy Cell Leukemia Market estimates & forecasts by Therapy 2019-2029 (USD Billion)
TABLE 4. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Hairy Cell Leukemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Hairy Cell Leukemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Hairy Cell Leukemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Hairy Cell Leukemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Hairy Cell Leukemia Market
TABLE 69. List of primary sources, used in the study of global Hairy Cell Leukemia Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered